152 related articles for article (PubMed ID: 30156420)
1. Impact of Intermolecular Interactions, Dimeric Structures on the Glass Forming Ability of Naproxen, and a Series of Its Derivatives.
Minecka A; Kaminska E; Tarnacka M; Grudzka-Flak I; Bartoszek M; Wolnica K; Dulski M; Kaminski K; Paluch M
Mol Pharm; 2018 Oct; 15(10):4764-4776. PubMed ID: 30156420
[TBL] [Abstract][Full Text] [Related]
2. Does the molecular mobility and flexibility of the saccharide ring affect the glass-forming ability of naproxen in binary mixtures?
Minecka A; Kamińska E; Tarnacka M; Jurkiewicz K; Talik A; Wolnica K; Dulski M; Kasprzycka A; Spychalska P; Garbacz G; Kamiński K; Paluch M
Eur J Pharm Sci; 2020 Jan; 141():105091. PubMed ID: 31655208
[TBL] [Abstract][Full Text] [Related]
3. Influence of Annealing in the Close Vicinity of
Kamińska E; Minecka A; Tarnacka M; Hachuła B; Kamiński K; Paluch M
Mol Pharm; 2020 Mar; 17(3):990-1000. PubMed ID: 31961694
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Chain Length and Topology of the Acetylated Oligosaccharide on the Crystallization Tendency of Naproxen from Amorphous Binary Mixtures.
Minecka A; Tarnacka M; Jurkiewicz K; Hachuła B; Wrzalik R; Kamiński K; Paluch M; Kamińska E
Mol Pharm; 2021 Jan; 18(1):347-358. PubMed ID: 33355470
[TBL] [Abstract][Full Text] [Related]
5. Studying of crystal growth and overall crystallization of naproxen from binary mixtures.
Kaminska E; Madejczyk O; Tarnacka M; Jurkiewicz K; Kaminski K; Paluch M
Eur J Pharm Biopharm; 2017 Apr; 113():75-87. PubMed ID: 28034808
[TBL] [Abstract][Full Text] [Related]
6. Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen.
Ueda H; Wakabayashi S; Kikuchi J; Ida Y; Kadota K; Tozuka Y
Mol Pharm; 2015 Apr; 12(4):1050-61. PubMed ID: 25654583
[TBL] [Abstract][Full Text] [Related]
7. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.
d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M
Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296
[TBL] [Abstract][Full Text] [Related]
8. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
[TBL] [Abstract][Full Text] [Related]
9. Studying the Impact of Modified Saccharides on the Molecular Dynamics and Crystallization Tendencies of Model API Nifedipine.
Kaminska E; Tarnacka M; Wlodarczyk P; Jurkiewicz K; Kolodziejczyk K; Dulski M; Haznar-Garbacz D; Hawelek L; Kaminski K; Wlodarczyk A; Paluch M
Mol Pharm; 2015 Aug; 12(8):3007-19. PubMed ID: 26101945
[TBL] [Abstract][Full Text] [Related]
10. A Strategy for Co-former Selection to Design Stable Co-amorphous Formations Based on Physicochemical Properties of Non-steroidal Inflammatory Drugs.
Ueda H; Muranushi N; Sakuma S; Ida Y; Endoh T; Kadota K; Tozuka Y
Pharm Res; 2016 Apr; 33(4):1018-29. PubMed ID: 26700604
[TBL] [Abstract][Full Text] [Related]
11. Impact of Supramolecular Aggregation on the Crystallization Kinetics of Organic Compounds from the Supercooled Liquid State.
Kalra A; Tishmack P; Lubach JW; Munson EJ; Taylor LS; Byrn SR; Li T
Mol Pharm; 2017 Jun; 14(6):2126-2137. PubMed ID: 28485947
[TBL] [Abstract][Full Text] [Related]
12. Glass-forming ability of compounds in marketed amorphous drug products.
Wyttenbach N; Kuentz M
Eur J Pharm Biopharm; 2017 Mar; 112():204-208. PubMed ID: 27903457
[TBL] [Abstract][Full Text] [Related]
13. Formulation of co-amorphous systems from naproxen and naproxen sodium and in situ monitoring of physicochemical state changes during dissolution testing by Raman spectroscopy.
Ueda H; Peter Bøtker J; Edinger M; Löbmann K; Grohganz H; Müllertz A; Rades T; Østergaard J
Int J Pharm; 2020 Sep; 587():119662. PubMed ID: 32682958
[TBL] [Abstract][Full Text] [Related]
14. Computational predictions of glass-forming ability and crystallization tendency of drug molecules.
Alhalaweh A; Alzghoul A; Kaialy W; Mahlin D; Bergström CA
Mol Pharm; 2014 Sep; 11(9):3123-32. PubMed ID: 25014125
[TBL] [Abstract][Full Text] [Related]
15. Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy.
Sibik J; Löbmann K; Rades T; Zeitler JA
Mol Pharm; 2015 Aug; 12(8):3062-8. PubMed ID: 26090554
[TBL] [Abstract][Full Text] [Related]
16. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
17. Crystallization and dissolution behavior of naproxen/polyethylene glycol solid dispersions.
Zhu Q; Toth SJ; Simpson GJ; Hsu HY; Taylor LS; Harris MT
J Phys Chem B; 2013 Feb; 117(5):1494-500. PubMed ID: 23320811
[TBL] [Abstract][Full Text] [Related]
18. Novel drug-drug salt crystals of metformin with ibuprofen or naproxen: Improved solubility, dissolution rate, and synergistic antinociceptive effects.
Qin HM; Luo ZK; Zhou HL; Zhu J; Xiao XY; Xiao Y; Zhuang T; Zhang GS
Int J Pharm; 2024 May; 657():124126. PubMed ID: 38626845
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen bonding in lignin: a Fourier transform infrared model compound study.
Kubo S; Kadla JF
Biomacromolecules; 2005; 6(5):2815-21. PubMed ID: 16153123
[TBL] [Abstract][Full Text] [Related]
20. Impact of inter- and intramolecular interactions on the physical stability of indomethacin dispersed in acetylated saccharides.
Kaminska E; Adrjanowicz K; Tarnacka M; Kolodziejczyk K; Dulski M; Mapesa EU; Zakowiecki D; Hawelek L; Kaczmarczyk-Sedlak I; Kaminski K
Mol Pharm; 2014 Aug; 11(8):2935-47. PubMed ID: 25011022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
